|
The Pharmaceutical Journal |
||
|
PDF* 75K |
|
Remuneration
|
GSKLow discountFrom Mr R. Lamb, MRPharmS I would urge all independent pharmacy contractors immediately to inspect their GlaxoSmithKline statements for January which were recently posted to their home addresses. The discount received is so low that GSK products should carry a warning on all their packs that "dispensing this product will seriously damage your wealth". The discount bands used to calculate the final figure highlight the problem of zero discount given on the first £500 of products purchased per month, which makes a nonsense of the higher rates offered. For purchases of UK-sourced GSK products worth £3,800 I received a miserly 7.5 per cent discount this is ironic when my National Health Service deducted discount is 11 per cent. I suggest we use our "local influence" with general practitioners and practice nurses to discuss asthma and migraine prescribing policies. I find those cost analysis bar graphs that have GSK products going off the scale highly influential at such meetings, especially when I am able to suggest alternative cost-effective drug treatments. A quick sharp lesson in zero prescribing should bring GSK to its senses. Roy Lamb The pharmacist's friend?From Mr S. S. Kalsi, MRPharmS Has anyone checked their rebate from GlaxoSmithKline? The 7 per cent is a myth. After the first £500 with no discount and after the zero discount items I have netted a 3.7 per cent rebate. Meanwhile the Government deducts a 10 per cent discount on average. As for receiving the money well before the settlement date, the cheque arrived on the 27 February. By the time we cleared it, assuming immediate deposit, the bill would already have been settled for two to three days. The pharmacist's friend? I hardly think so. As always, nothing changes. Surinder Singh Kalsi
|
|||||
|
Previous Topic (Baddy chemists) |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal